U.S. Physical Therapy Reports Strong Q3 2025 Performance

An announcement from US Physical Therapy ( (USPH) ) is now available.

U.S. Physical Therapy reported a strong financial performance for the third quarter of 2025, with a significant increase in adjusted EBITDA and net income compared to the same period in 2024. The company saw a 17.8% rise in total revenue from physical therapy operations and an 18.0% increase in total patient visits, driven by clinic additions and a record-high volume of daily patient visits per clinic. The company also expanded its clinic network by adding 18 new clinics and acquiring a 60% equity interest in a three-clinic practice. Additionally, the Board of Directors declared a quarterly dividend of $0.45 per share, reflecting confidence in the company’s ongoing growth and financial stability.

The most recent analyst rating on (USPH) stock is a Buy with a $103.00 price target. To see the full list of analyst forecasts on US Physical Therapy stock, see the USPH Stock Forecast page.

Spark’s Take on USPH Stock

According to Spark, TipRanks’ AI Analyst, USPH is a Outperform.

US Physical Therapy’s overall stock score of 71 reflects its strong financial performance and positive technical indicators. The company’s robust cash flow and operational efficiency are key strengths, while the high P/E ratio suggests a premium valuation. Positive sentiment from the latest earnings call further supports the score, despite challenges with Medicare rate reductions and staffing issues.

To see Spark’s full report on USPH stock, click here.

More about US Physical Therapy

U.S. Physical Therapy, Inc. is a national operator of outpatient physical therapy clinics and a provider of industrial injury prevention services.

Average Trading Volume: 155,376

Technical Sentiment Signal: Buy

Current Market Cap: $1.32B

Learn more about USPH stock on TipRanks’ Stock Analysis page.